Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTU-520 patch vs placebo in patients with onychomycosis
jRCT2080221109Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in onychomycosis comparing HTU-520 terbinafine patch with HTU-520 placebo patch (2 arms).
02
Drugs
Terbinafine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on jRCT2080221109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221109.